A pioneering treatment, an antibody termed PRN100, is to be given to a patient with sporadic Creutzfeldt-Jakob disease for the first time.
Browsing: Clinical > Infection control
The WHO are amongst those aiding the Government of Zimbabwe to begin an oral cholera vaccination campaign yesterday, in efforts to immunize 1.4 million people living in high-risk regions in Harare, the capital of Zimbabwe.
Researchers have reported that, despite control efforts, the incidence of visceral leishmaniasis has risen between 1990 and 2016.
Continuous mass distribution of azithromycin in northern Ethiopia is effective for trachoma prevention but doesn’t eliminate the disease entirely, according to new research.
A study in 20 patients has demonstrated that transplantation followed by antiviral therapy has been successful in patients receiving kidneys from hepatitis C-infected donors.
Glenn Tillotson gives us an overview of the 14th Biennial Congress of the Anaerobe Society of the Americas, including updates on the microbiome and new therapies.